Comparable to KMT2Ar, NPM1c AML is characterized by overexpression of HOXA/HOXB and menin while a blockage of the MLL–menin complex can reinduce differentiation leading to the inclusion of these patients in ongoing clinical investigations [6]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.